Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
As one of the most studied GHRH research peptides in Australia, Tesamorelin appears across endocrine and metabolic research models, which is why its a common choice for researchers working in this area
Whilst the little evidence we have supports no great risk, clinical trial and longer term data is lacking
It works by inhibiting the NNMT enzymea known contributor to fat storage and metabolic slowdown
Note: All cited studies refer to in-vitro and animal model research
Most Popular Beyond weight loss Metabolic problems like blood sugar dysregulation can return after stopping a GLP-1, Biermann says
US$ 23.59
US$ 24.69
US$ 25.70
US$ 27.31
